TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts

Area of Science:

• Developmental Biology
• Hematopoiesis
• Extracellular Matrix Biology

Background:

• The fetal liver is the primary site of embryonic hematopoiesis, with hematopoietic stem cells (HSCs) colonizing it.
• Integrin beta-1 on HSCs is vital for their adherence and colonization of the fetal liver, mediated by extracellular matrix (ECM) interactions.
• Regulation of ECM production within the fetal liver microenvironment remains poorly understood.

Purpose of the Study:

• To investigate the cellular source and regulatory mechanisms of ECM production in the developing fetal liver.
• To elucidate the role of specific signaling pathways in controlling ECM deposition essential for HSC colonization.

Main Methods:

• Flow cytometry was employed to isolate and analyze distinct fetal liver cell populations.
• Quantitative analysis of ECM gene and protein expression was performed.
• Transforming growth factor-beta 1 (TGF-β1) signaling pathway was investigated using inhibitors in vivo.

Main Results:

• ECM gene and protein expression were found to be predominantly localized in sorted hepatoblasts.
• TGF-β1, expressed by multiple fetal liver cell types, was identified as a key regulator, binding to TGF-beta receptor type-2 on hepatoblasts to stimulate ECM production.
• Inhibition of TGF-β1 signaling in embryonic mouse models significantly reduced fetal liver ECM gene expression.

Conclusions:

• Hepatoblasts are the main producers of ECM components in the fetal liver.
• TGF-β1 signaling is a critical regulator of ECM production by hepatoblasts, influencing the fetal liver microenvironment.
• These findings provide insights into the developmental regulation of the hematopoietic niche.